Background illustration for clinical trials search

Paid Clinical Trials Bakersfield

Discover 49 paid clinical trials in Bakersfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

for
Asthma
Location: Bakersfield CA, Huntington Beach CA, Mission Viejo CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 12 - 17

Code: NCT05757102

Phase3, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Bakersfield CA, West Hollywood CA, Palm Springs CA,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase2, Recruiting

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

for
Non-muscle-invasive Bladder Cancer
Location: Bakersfield CA, Downey CA, Murrieta CA, Mesa AZ,
Sponsor: SURGE Therapeutics

Sex: All

Age: 18+

Code: NCT05710848

Phase1, Phase2, Recruiting

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

for
Stargardt Disease
Location: Bakersfield CA, Bellaire TX, Pittsburgh PA
Sponsor: Ray Therapeutics, Inc.

Sex: All

Age: 16+

Code: NCT07439887

Phase1, Phase2, Recruiting

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

for
Dysphotopsia, Posterior Capsule Opacification, Visual Acuity,
Location: Bakersfield CA
Sponsor: Dr. Daniel H. Chang, MD

Sex: All

Age: 22+

Code: NCT07213167

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Bakersfield CA, Orange CA, Phoenix AZ, Queen Creek AZ,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Bakersfield CA, San Diego CA, Orange CA, Irvine CA,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Bakersfield CA, Los Angeles CA, Torrance CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Bakersfield CA, Santa Monica CA, Los Angeles CA,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

for
Bladder Cancer, Urinary Bladder Neoplasms
Location: Bakersfield CA, Austin TX, Myrtle Beach SC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07222488

Phase1, Phase2, Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Bakersfield CA, Queen Creek AZ, Arlington TX,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT07480356

Phase3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Bakersfield CA, Orange CA, Chandler AZ, Queen Creek AZ,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Bakersfield CA, Santa Barbara CA, Austin TX,
Sponsor: Ocular Therapeutix, Inc.

Sex: All

Age: 50+

Code: NCT07516132

Phase3, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bakersfield CA, Oxnard CA, Encino CA, Torrance CA,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Bakersfield CA, Oxnard CA, Los Angeles CA, Glendale CA,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Bakersfield CA, Oxnard CA, Los Angeles CA, Glendale CA,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase3, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Bakersfield CA, Solvang CA, Los Angeles CA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Bakersfield CA, Glendale CA, Santa Monica CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

for
Melanoma Stage IV, Solid Tumor
Location: Bakersfield CA, Los Angeles CA, Fullerton CA,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06425926

Phase1, Phase2, Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for
Non-small Cell Lung Cancer
Location: Bakersfield CA, Beverly Hills CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06345729

Phase3, Recruiting